This information is intended for US healthcare professionals.

Co-pay Support Injectable PrEP Option
DESCOVY® (emtricitabine/tenofovir alafenamide) brand logo. See BOXED WARNING.

Get started with the smallest pill for daily oral PrEP1-3

DESCOVY® (FTC/TAF)

(emtricitabine 200 mg/tenofovir alafenamide 25 mg) tablets

TRUVADA® (FTC/TDF)

(emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) tablets

Pills shown are not actual size. DESCOVY actual size is 13 mm W x 6 mm H x 4 mm D. TRUVADA actual size is 19 mm W x 9 mm H x 7 mm D.

Please see full Prescribing Information for DESCOVY FOR PrEP, including BOXED WARNING.

Please see full Prescribing Information for TRUVADA, including BOXED WARNING.

There’s no generic version of DESCOVY FOR PrEP®.3,4

DESCOVY Packaging

NDC Number
Bottle 61958-2002-1

Source: IQVIA® LAAD Weekly, 01/20/2026 through 05/29/2026.1*

Simple dosing and oral administration with DESCOVY FOR PrEP1,3,5

One pill, once daily

No food requirements

Same-day start

May be started same day upon confirmation of HIV-negative test results

*This information is an estimate derived from the use of information under license from the following IQVIA information service: IQVIA Longitudinal Access and Adjudication Data (LAAD) for the period WE 01/20/2026 through WE 05/29/2026. IQVIA expressly reserves all rights, including rights of copying, distribution and republication.1

Ready to prescribe DESCOVY, if clinically appropriate?
Any licensed provider can prescribe PrEP.

You may also be interested in:

INITIATING DESCOVY

DESCOVY CO-PAY SUPPORT

FTC/TAF=emtricitabine/tenofovir alafenamide; FTC/TDF=emtricitabine/tenofovir disoproxil fumarate; IQVIA LAAD=IMS Health, Quintiles, and VIA Longitudinal Access and Adjudication Data; PrEP=pre-exposure prophylaxis.